Everything PR News
Crisis PR & Crisis Communications

Will Sharapova’s Ban Hurt Tennis More Than Her?

EPR Editorial TeamBy EPR Editorial Team2 min read
Will Sharapova’s Ban Hurt Tennis More Than Her?
Share
There’s no doubt, Maria Sharapova’s golden child image has taken a blow in recent weeks. When the story of doping allegations hit the news, the tennis star, most well-known for her poise in endorsements rather than her poise on the court, had a serious PR crisis on her hands. When your brand is your image, any whiff of a cheating or doping scandal becomes headline news. The five-time Grand Slam champion did herself plenty of favors in the early going, though, coming right out and admitting her faults and asking for forgiveness. In a second solid PR move, Sharapova gave herself a solid and reasonable alibi for her indiscretions. The drug found in her system, meldonium, was allegedly prescribed for legitimate medical reasons. Sharapova admitted taking the drug for the better part of a decade, but she coupled that admission with a reasonable excuse. Sharapova then completed a trifecta of solid PR responses by claiming the issue was an honest mistake. She never lied about the substance, she simply didn’t realize it was banned. The list of banned substances was updated, she said, but she didn’t read it. People who want to believe her did so. Easy mistake, right? But the people who WANTED to believe did not necessarily include Sharapova’s sponsors. So far, the fallout on that score has been substantial. Nike, Porsche, and Tag Heuer have all stopped Sharapova’s endorsement deals. And they did so almost immediately, a move that is certain to sting. Now, it’s worth noting that these deals have been suspended, not rescinded. That’s fairly common for a brand to overreact to avoid getting caught up in any nefarious scenarios surrounding their “faces”. Any or all of these brands could update their agreements with Sharapova once all the smoke blows over. The next factor is how long the punishment may last. World Tennis could impose a four-year ban on the player, essentially ending her competitive career. If that happens, expect the endorsement deals to dry up permanently. So, Sharapova’s next PR focus must be on convincing tennis’ governing body she’s worth more to them on the court than off it. Win that battle and the endorsements will take care of themselves.
TagsCrisis PR & Crisis CommunicationsEntertainment & Media
EPR Editorial Team
Written by
EPR Editorial Team

The Everything-PR Editorial Team produces reporting, research, and analysis across thirty verticals — communications, reputation, AI visibility, public affairs, media systems, and digital discovery in the answer-engine era. Publishing since 2009.

Other news

See all
Midjourney
EPR Editorial Team · 05/29/2026

Midjourney

Midjourney won AI image generation on aesthetic. The model whose outputs other tools chase. EPR ranks Midjourney first for creative-director adoption and aesthetic quality.

Nous Research: Who They Are and Why They Built Hermes
EPR Editorial Team · 05/29/2026

Nous Research: Who They Are and Why They Built Hermes

Nous Research is an independent AI lab focused on agent infrastructure, model post-training, and open-weight model work. Their recent Hermes project, a harness for Claude Code, has brought them unexpected attention. This article profiles Nous Research, explains what Hermes does, and explores why the lab is building on top of another company's coding agent.

Cursor IDE
EPR Editorial Team · 05/29/2026

Cursor IDE

Cursor IDE is the AI-native code editor that won the developer market. 70 percent of the Fortune 1,000 are customers. $2B ARR in three years — the fastest B2B scaling on record. EPR ranks Cursor first in coding assistants.

Never Miss a Headline

Daily PR headlines, weekly long-form analysis, and our proprietary research drops — straight to your inbox.